The prostate biopsy method shows a high false negative result because the suspicious tissue considered as cancer is not confirmed during tissue sampling. Thus, repeated biopsy procedures and diagnostic errors in relation to prostate cancer frequently occur. The purpose of this research is to enhance the prostate cancer detection rate by using microfluidic electrical impedance spectroscopy (μEIS), which allows real-time measurement of the electrical impedance of a single human prostate normal cell and cancer cell. The μEIS was equipped with a movable flexible membrane, which is operated by pneumatic pressure to capture the single cell on the surface of sensing electrodes. The forced tight contact between the cell and electrodes makes it possible to measure the electrical characteristics of the cell with a high sensitivity. The μEIS discriminates well between normal human prostate cells (RWPE-1) and cancer cells (PC-3) at 8.7 kHz based on the electrical signal responses of the cells. The average difference rates of admittance magnitude and susceptance are 54.55% and 54.59%, respectively. The developed μEIS also shows high repeatability, which was verified by a deionized water test conducted before and after each cell assay; the maximum variance of both the impedance and admittance at 8.7 kHz was as small as 9.48%.
Skip Nav Destination
Article navigation
July 2013
Research Article|
August 26 2013
Discrimination between the human prostate normal cell and cancer cell by using a novel electrical impedance spectroscopy controlling the cross-sectional area of a microfluidic channel
Giseok Kang;
Giseok Kang
1
Department of Medical System Engineering, Gwangju Institute of Science and Technology (GIST)
, Gwangju 500-712, South Korea
Search for other works by this author on:
Young-jae Kim;
Young-jae Kim
2
Department of Electrical and Computer Engineering, College of Engineering, Seoul National University
, Seoul 151-744, South Korea
Search for other works by this author on:
Hong-sang Moon;
Hong-sang Moon
3
Department of Urology, College of Medicine, Hanyang University
, Guri 471-701, South Korea
Search for other works by this author on:
Jeong-Woo Lee;
Jeong-Woo Lee
3
Department of Urology, College of Medicine, Hanyang University
, Guri 471-701, South Korea
Search for other works by this author on:
Tag-Keun Yoo;
Tag-Keun Yoo
4
Department of Urology, Eulji Medical Center, Eulji University School of Medicine
, Seoul 139-872, South Korea
Search for other works by this author on:
Kwangsung Park;
Kwangsung Park
5
Department of Urology, Chonnam National University Medical School
, Gwangju 501-757, South Korea
Search for other works by this author on:
Jong-Hyun Lee
Jong-Hyun Lee
1
Department of Medical System Engineering, Gwangju Institute of Science and Technology (GIST)
, Gwangju 500-712, South Korea
6
Department of Mechatronics, Gwangju Institute of Science and Technology (GIST)
, Gwangju 500-712, South Korea
Search for other works by this author on:
Biomicrofluidics 7, 044126 (2013)
Article history
Received:
April 29 2013
Accepted:
August 06 2013
Citation
Giseok Kang, Young-jae Kim, Hong-sang Moon, Jeong-Woo Lee, Tag-Keun Yoo, Kwangsung Park, Jong-Hyun Lee; Discrimination between the human prostate normal cell and cancer cell by using a novel electrical impedance spectroscopy controlling the cross-sectional area of a microfluidic channel. Biomicrofluidics 1 July 2013; 7 (4): 044126. https://doi.org/10.1063/1.4818838
Download citation file:
Sign in
Don't already have an account? Register
Sign In
You could not be signed in. Please check your credentials and make sure you have an active account and try again.
Pay-Per-View Access
$40.00
Citing articles via
Microfluidics for foodborne bacteria analysis: Moving toward multiple technologies integration
Gaowa Xing, Jin-Ming Lin
Wicking pumps for microfluidics
Behrouz Aghajanloo, Wil Losereewanich, et al.
Lab-on-a-chip models of cardiac inflammation
Anna Maria Popovic, Matthew Ho Cheong Lei, et al.
Related Content
Quick chip assay using locked nucleic acid modified epithelial cell adhesion molecule and nucleolin aptamers for the capture of circulating tumor cells
Biomicrofluidics (September 2015)
Enhanced blebbing as a marker for metastatic prostate cancer
Biomicrofluidics (May 2019)
Aggressive prostate cancer cell nuclei have reduced stiffness
Biomicrofluidics (January 2018)
Probes for noninvasive biological visualization and biosensing of cancer cells
Appl. Phys. Rev. (November 2023)